{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:40:13Z","timestamp":1791297613575,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1038\/ncpcardio0827","type":"journal-article","created":{"date-parts":[[2007,4,25]],"date-time":"2007-04-25T09:12:05Z","timestamp":1177492325000},"page":"254-262","source":"Crossref","is-referenced-by-count":142,"title":["Calcific aortic stenosis: an update"],"prefix":"10.1038","volume":"4","author":[{"given":"Nalini M","family":"Rajamannan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert O","family":"Bonow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahbudin H","family":"Rahimtoola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpcardio0827_CR1","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/0735-1097(93)90249-Z","volume":"21","author":"M Lindroos","year":"1993","unstructured":"Lindroos M  et al. (1993) Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 21: 1220\u20131225","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"BFncpcardio0827_CR2","first-page":"S61","volume":"38","author":"J Ross Jr","year":"1968","unstructured":"Ross J Jr and Braunwald E (1968) Aortic stenosis. Circulation 38 (Suppl 1): S61\u2013S67","journal-title":"Circulation"},{"key":"BFncpcardio0827_CR3","first-page":"45","volume-title":"An era in cardiovascular medicine","author":"SH Rahimtoola","year":"1991","unstructured":"Rahimtoola SH (1991) Perspectives on valvular heart disease: update II. In An era in cardiovascular medicine, 45\u201370 (Eds Knoebel SB and Dack S) New York: Elsevier"},{"key":"BFncpcardio0827_CR4","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/01.CIR.0000155623.48408.C5","volume":"111","author":"WC Roberts","year":"2005","unstructured":"Roberts WC and Ko JM (2005) Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 111: 920\u2013925","journal-title":"Circulation"},{"key":"BFncpcardio0827_CR5","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","volume":"29","author":"BF Stewart","year":"1997","unstructured":"Stewart BF  et al. (1997) Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 29: 630\u2013634","journal-title":"J Am Coll Cardiol"},{"key":"BFncpcardio0827_CR6","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/0002-9149(87)91144-1","volume":"59","author":"WS Aronow","year":"1987","unstructured":"Aronow WS  et al. (1987) Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol 59: 998\u2013999","journal-title":"Am J Cardiol"},{"key":"BFncpcardio0827_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJM199907153410302","volume":"341","author":"CM Otto","year":"1999","unstructured":"Otto CM  et al. (1999) Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 341: 142\u2013147","journal-title":"N Engl J Med"},{"key":"BFncpcardio0827_CR8","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1161\/hc4101.097527","volume":"104","author":"K Pohle","year":"2001","unstructured":"Pohle K  et al. (2001) Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation 104: 1927\u20131932","journal-title":"Circulation"},{"key":"BFncpcardio0827_CR9","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/01.ATV.16.4.523","volume":"16","author":"KD O'Brien","year":"1996","unstructured":"O'Brien KD  et al. (1996) Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol 16: 523\u2013532","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio0827_CR10","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1161\/01.ATV.19.5.1218","volume":"19","author":"M Olsson","year":"1999","unstructured":"Olsson M  et al. (1999) Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 19: 1218\u20131222","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio0827_CR11","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1161\/01.CIR.90.2.844","volume":"90","author":"CM Otto","year":"1994","unstructured":"Otto CM  et al. (1994) Characterization of the early lesion of 'degenerative' valvular aortic stenosis: histological and immunohistochemical studies. Circulation 90: 844\u2013853","journal-title":"Circulation"},{"key":"BFncpcardio0827_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/0002-9149(84)90298-4","volume":"54","author":"DL Sprecher","year":"1984","unstructured":"Sprecher DL  et al. (1984) Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol 54: 20\u201330","journal-title":"Am J Cardiol"},{"key":"BFncpcardio0827_CR13","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMc031360","volume":"349","author":"NM Rajamannan","year":"2003","unstructured":"Rajamannan NM  et al. (2003) Hypercholesterolemic aortic-valve disease. N Engl J Med 349: 717\u2013718","journal-title":"N Engl J Med"},{"key":"BFncpcardio0827_CR14","first-page":"371","volume":"10","author":"NM Rajamannan","year":"2001","unstructured":"Rajamannan NM  et al. (2001) Experimental hypercholesterolemia induces apoptosis in the aortic valve. J Heart Valve Dis 10: 371\u2013374","journal-title":"J Heart Valve Dis"},{"key":"BFncpcardio0827_CR15","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1161\/01.CIR.0000017435.87463.72","volume":"105","author":"NM Rajamannan","year":"2002","unstructured":"Rajamannan NM  et al. (2002) Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 105: 2660\u20132665","journal-title":"Circulation"},{"key":"BFncpcardio0827_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nature03940","volume":"437","author":"V Garg","year":"2005","unstructured":"Garg V  et al. (2005) Mutations in NOTCH1 cause aortic valve disease. Nature 437: 270\u2013274","journal-title":"Nature"},{"key":"BFncpcardio0827_CR17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/heart.85.6.635","volume":"85","author":"JR Ortlepp","year":"2001","unstructured":"Ortlepp JR  et al. (2001) The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 85: 635\u2013638","journal-title":"Heart"},{"key":"BFncpcardio0827_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1034\/j.1399-0004.2001.600511.x","volume":"60","author":"SD Avakian","year":"2001","unstructured":"Avakian SD  et al. (2001) Apolipoproteins AI, B, and E polymorphisms in severe aortic valve stenosis. Clin Genet 60: 381\u2013384","journal-title":"Clin Genet"},{"key":"BFncpcardio0827_CR19","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1161\/01.CIR.92.8.2163","volume":"92","author":"KD O'Brien","year":"1995","unstructured":"O'Brien KD  et al. (1995) Osteopontin is expressed in human aortic valvular lesions. Circulation 92: 2163\u20132168","journal-title":"Circulation"},{"key":"BFncpcardio0827_CR20","first-page":"427","volume":"20","author":"V Liebe","year":"2006","unstructured":"Liebe V  et al. (2006) Coagulation activation is associated with interleukin-6 plasma levels in patients with mechanical prosthetic heart valves. In Vivo 20: 427\u2013430","journal-title":"In Vivo"},{"key":"BFncpcardio0827_CR21","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/S0735-1097(01)01484-X","volume":"38","author":"A Galante","year":"2001","unstructured":"Galante A  et al. (2001) C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol 38: 1078\u20131081","journal-title":"J Am Coll Cardiol"},{"key":"BFncpcardio0827_CR22","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/S0046-8177(03)00245-4","volume":"34","author":"Y Soini","year":"2003","unstructured":"Soini Y  et al. (2003) Angiogenesis is involved in the pathogenesis of nonrheumatic aortic valve stenosis. Hum Pathol 34: 756\u2013763","journal-title":"Hum Pathol"},{"key":"BFncpcardio0827_CR23","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1161\/CIRCULATIONAHA.104.473165","volume":"111","author":"NM Rajamannan","year":"2005","unstructured":"Rajamannan NM  et al. (2005) Calcified rheumatic valve neoangiogenesis is associated with vascular endothelial growth factor expression and osteoblast-like bone formation. Circulation 111: 3296\u20133301","journal-title":"Circulation"},{"key":"BFncpcardio0827_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0003-4975(02)04312-6","volume":"75","author":"B Jian","year":"2003","unstructured":"Jian B  et al. (2003) Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg 75: 457\u2013465","journal-title":"Ann Thorac Surg"},{"key":"BFncpcardio0827_CR25","first-page":"869","volume":"16","author":"JJ Kaden","year":"2005","unstructured":"Kaden JJ  et al. (2005) Tumor necrosis factor alpha promotes an osteoblast-like phenotype in human aortic valve myofibroblasts: a potential regulatory mechanism of valvular calcification. Int J Mol Med 16: 869\u2013872","journal-title":"Int J Mol Med"},{"key":"BFncpcardio0827_CR26","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1161\/01.CIR.0000035655.45453.D2","volume":"106","author":"KD O'Brien","year":"2002","unstructured":"O'Brien KD  et al. (2002) Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 106: 2224\u20132230","journal-title":"Circulation"},{"key":"BFncpcardio0827_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.yexcr.2004.04.034","volume":"298","author":"F Chalajour","year":"2004","unstructured":"Chalajour F  et al. (2004) Angiogenic activation of valvular endothelial cells in aortic valve stenosis. Exp Cell Res 298: 455\u2013464","journal-title":"Exp Cell Res"},{"key":"BFncpcardio0827_CR28","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/clc.4960141210","volume":"14","author":"ER Mohler","year":"1991","unstructured":"Mohler ER  et al. (1991) Development and progression of aortic valve stenosis: atherosclerosis risk factors\u2014a causal relationship? A clinical morphologic study. Clin Cardiol 14: 995\u2013999","journal-title":"Clin Cardiol"},{"key":"BFncpcardio0827_CR29","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1136\/heart.89.7.801","volume":"89","author":"NM Rajamannan","year":"2003","unstructured":"Rajamannan NM  et al. (2003) Calcific aortic stenosis: from bench to the bedside\u2014emerging clinical and cellular concepts. Heart 89: 801\u2013805","journal-title":"Heart"},{"key":"BFncpcardio0827_CR30","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1161\/01.CIR.0000070591.21548.69","volume":"107","author":"NM Rajamannan","year":"2003","unstructured":"Rajamannan NM  et al. (2003) Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 107: 2181\u20132184","journal-title":"Circulation"},{"key":"BFncpcardio0827_CR31","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1161\/01.CIR.103.11.1522","volume":"103","author":"ER Mohler III","year":"2001","unstructured":"Mohler ER III  et al. (2001) Bone formation and inflammation in cardiac valves. Circulation 103: 1522\u20131528","journal-title":"Circulation"},{"key":"BFncpcardio0827_CR32","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.jacc.2006.02.040","volume":"47","author":"FC Caira","year":"2006","unstructured":"Caira FC  et al. (2006) Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol 47: 1707\u20131712","journal-title":"J Am Coll Cardiol"},{"key":"BFncpcardio0827_CR33","first-page":"560","volume":"13","author":"JJ Kaden","year":"2004","unstructured":"Kaden JJ  et al. (2004) Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis. J Heart Valve Dis 13: 560\u2013566","journal-title":"J Heart Valve Dis"},{"key":"BFncpcardio0827_CR34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1161\/01.ATV.17.3.547","volume":"17","author":"ER Mohler III","year":"1997","unstructured":"Mohler ER III  et al. (1997) Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol 17: 547\u2013552","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio0827_CR35","first-page":"353","volume":"14","author":"P Mathieu","year":"2005","unstructured":"Mathieu P  et al. (2005) Calcification of human valve interstitial cells is dependent on alkaline phosphatase activity. J Heart Valve Dis 14: 353\u2013357","journal-title":"J Heart Valve Dis"},{"key":"BFncpcardio0827_CR36","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jacc.2005.11.023","volume":"47","author":"SH Rahimtoola","year":"2006","unstructured":"Rahimtoola SH (2006) The year in valvular heart disease. J Am Coll Cardiol 47: 427\u2013439","journal-title":"J Am Coll Cardiol"},{"key":"BFncpcardio0827_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11154-006-9003-3","volume":"7","author":"ML Johnson","year":"2006","unstructured":"Johnson ML and Rajamannan N (2006) Diseases of Wnt signaling. Rev Endocr Metab Disord 7: 41\u201349","journal-title":"Rev Endocr Metab Disord"},{"issue":"Suppl 9","key":"BFncpcardio0827_CR38","first-page":"I229","volume":"112","author":"NM Rajamannan","year":"2005","unstructured":"Rajamannan NM  et al. (2005) Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation 112 (Suppl 9): I229\u2013I234","journal-title":"Circulation"},{"key":"BFncpcardio0827_CR39","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1172\/JCI24140","volume":"115","author":"JS Shao","year":"2005","unstructured":"Shao JS  et al. (2005) Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 115: 1210\u20131220","journal-title":"J Clin Invest"},{"key":"BFncpcardio0827_CR40","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1056\/NEJM200008313430903","volume":"343","author":"R Rosenhek","year":"2000","unstructured":"Rosenhek R  et al. (2000) Predictors of outcome in severe asymptomatic aortic stenosis. N Engl J Med 343: 611\u2013617","journal-title":"N Engl J Med"},{"key":"BFncpcardio0827_CR41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1136\/jim-52-03-33","volume":"52","author":"KD O'Brien","year":"2004","unstructured":"O'Brien KD  et al. (2004) Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function. J Investig Med 52: 185\u2013191","journal-title":"J Investig Med"},{"key":"BFncpcardio0827_CR42","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1001\/archinte.165.8.858","volume":"165","author":"KD O'Brien","year":"2005","unstructured":"O'Brien KD  et al. (2005) Angiotensin-converting enzyme inhibitors and change in aortic valve calcium. Arch Intern Med 165: 858\u2013862","journal-title":"Arch Intern Med"},{"key":"BFncpcardio0827_CR43","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/hrt.2003.029785","volume":"91","author":"NM Rajamannan","year":"2005","unstructured":"Rajamannan NM  et al. (2005) Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart 91: 806\u2013810","journal-title":"Heart"},{"key":"BFncpcardio0827_CR44","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1161\/CIRCULATIONAHA.106.176857","volume":"114","author":"RO Bonow","year":"2006","unstructured":"American College of Cardiology\/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; Bonow RO  et al. (2006) ACC\/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114: e84\u2013e231","journal-title":"Circulation"},{"key":"BFncpcardio0827_CR45","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0002-9149(01)01821-5","volume":"88","author":"WS Aronow","year":"2001","unstructured":"Aronow WS  et al. (2001) Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol 88: 693\u2013695","journal-title":"Am J Cardiol"},{"key":"BFncpcardio0827_CR46","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1161\/hc4301.098249","volume":"104","author":"GM Novaro","year":"2001","unstructured":"Novaro GM  et al. (2001) Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation 104: 2205\u20132209","journal-title":"Circulation"},{"key":"BFncpcardio0827_CR47","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0735-1097(02)02496-8","volume":"40","author":"MF Bellamy","year":"2002","unstructured":"Bellamy MF  et al. (2002) Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 40: 1723\u20131730","journal-title":"J Am Coll Cardiol"},{"key":"BFncpcardio0827_CR48","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/S0140-6736(02)08161-8","volume":"359","author":"DM Shavelle","year":"2002","unstructured":"Shavelle DM  et al. (2002) HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet 359: 1125\u20131126","journal-title":"Lancet"},{"key":"BFncpcardio0827_CR49","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1056\/NEJMoa043876","volume":"352","author":"SJ Cowell","year":"2005","unstructured":"Cowell SJ  et al. (2005) A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 352: 2389\u20132397","journal-title":"N Engl J Med"},{"key":"BFncpcardio0827_CR50","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jacc.2006.07.072","volume":"49","author":"LM Moura","year":"2007","unstructured":"Moura LM  et al. (2007) Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 49: 554\u2013561","journal-title":"J Am Coll Cardiol"},{"key":"BFncpcardio0827_CR51","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1567-5688(03)91088-9","volume":"4","author":"A Rossebo","year":"2003","unstructured":"Rossebo A  et al. (2003) 3P-0870 Design of the Simvastatin and Szetimide in Aortic Stenosis (SEAS) Study [abstract]. Atheroscler Suppl 4: 253","journal-title":"Atheroscler Suppl"},{"key":"BFncpcardio0827_CR52","unstructured":"Rahimtoola SH (2004) Aortic valve disease. In Hurst's The Heart Manual of Cardiology, 1643\u20131679 (Eds Fuster V  et al.) New York: McGraw-Hill Medical"},{"key":"BFncpcardio0827_CR53","first-page":"568","volume-title":"Diseases of the Heart and Circulation","author":"P Wood","year":"1956","unstructured":"Wood P (1956) Aortic stenosis. In Diseases of the Heart and Circulation, 568\u2013583 (Ed Wood P) London: Eyre and Spootiswoode"},{"key":"BFncpcardio0827_CR54","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0894-7317(03)00472-3","volume":"16","author":"LM Beauchesne","year":"2003","unstructured":"Beauchesne LM  et al. (2003) Temporal variations in effective orifice area during ejection in patients with valvular aortic stenosis. J Am Soc Echocardiogr 16: 958\u2013964","journal-title":"J Am Soc Echocardiogr"},{"key":"BFncpcardio0827_CR55","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/hrt.13.2.153","volume":"13","author":"A Leatham","year":"1951","unstructured":"Leatham A (1951) The phonocardiogram of aortic stenosis. Br Heart J 13: 153\u2013158","journal-title":"Br Heart J"},{"key":"BFncpcardio0827_CR56","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1016\/S0735-1097(99)00093-5","volume":"33","author":"SH Rahimtoola","year":"1999","unstructured":"Rahimtoola SH (1999) \u201cProphylactic\u201d valve replacement for mild aortic valve disease at time of surgery for other cardiovascular disease?...No. J Am Coll Cardiol 33: 2009\u20132015","journal-title":"J Am Coll Cardiol"},{"key":"BFncpcardio0827_CR57","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1161\/01.CIR.101.16.1892","volume":"101","author":"SH Rahimtoola","year":"2000","unstructured":"Rahimtoola SH (2000) Severe aortic stenosis with low systolic gradient: the good and bad news. Circulation 101: 1892\u20131894","journal-title":"Circulation"},{"key":"BFncpcardio0827_CR58","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1161\/01.CIR.0000079171.43055.46","volume":"108","author":"JL Monin","year":"2003","unstructured":"Monin JL  et al. (2003) Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 108: 319\u2013324","journal-title":"Circulation"},{"key":"BFncpcardio0827_CR59","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/hrt.62.5.372","volume":"62","author":"MJ Griffith","year":"1989","unstructured":"Griffith MJ  et al. (1989) Inaccuracies in using aortic valve gradients alone to grade severity of aortic stenosis. Br Heart J 62: 372\u2013378","journal-title":"Br Heart J"},{"key":"BFncpcardio0827_CR60","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cpcardiol.2005.10.002","volume":"31","author":"C Bucciarelli-Ducci","year":"2006","unstructured":"Bucciarelli-Ducci C  et al. (2006) Contrast-enhanced cardiac magnetic resonance in the evaluation of myocardial infarction and myocardial viability in patients with ischemic heart disease. Curr Probl Cardiol 31: 128\u2013168","journal-title":"Curr Probl Cardiol"},{"key":"BFncpcardio0827_CR61","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0002-8703(89)90685-6","volume":"117","author":"SH Rahimtoola","year":"1989","unstructured":"Rahimtoola SH (1989) The hibernating myocardium. Am Heart J 117: 211\u2013221","journal-title":"Am Heart J"},{"key":"BFncpcardio0827_CR62","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jacc.2005.11.038","volume":"47","author":"SH Rahimtoola","year":"2006","unstructured":"Rahimtoola SH  et al. (2006) Hibernating myocardium: another piece of the puzzle falls into place. J Am Coll Cardiol 47: 978\u2013980","journal-title":"J Am Coll Cardiol"},{"key":"BFncpcardio0827_CR63","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0735-1097(02)02965-0","volume":"41","author":"SH Rahimtoola","year":"2003","unstructured":"Rahimtoola SH (2003) Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol 41: 893\u2013904","journal-title":"J Am Coll Cardiol"},{"key":"BFncpcardio0827_CR64","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jacc.2004.11.014","volume":"45","author":"SH Rahimtoola","year":"2005","unstructured":"Rahimtoola SH (2005) The year in valvular heart disease. J Am Coll Cardiol 45: 111\u201312255","journal-title":"J Am Coll Cardiol"}],"container-title":["Nature Clinical Practice Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpcardio0827.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpcardio0827","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncpcardio0827","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncpcardio0827.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:41:00Z","timestamp":1684438860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpcardio0827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["BFncpcardio0827"],"URL":"https:\/\/doi.org\/10.1038\/ncpcardio0827","relation":{},"ISSN":["1743-4297","1743-4300"],"issn-type":[{"value":"1743-4297","type":"print"},{"value":"1743-4300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}